World’s First Human Implant of a 3D-Printed Cornea Restores Sight
December 15, 2025
Background
Pinta disease, known as “carate” or “mal del Pinto,” causes discolored skin patches or lesions due to Treponema carateum bacteria. This chronic infection belongs to endemic treponematoses like syphilis and yaws. Transmission often happens during childhood through direct skin contact. Factors enabling pinta’s prevalence include poor hygiene conditions, overcrowded living spaces, and restricted healthcare access in affected areas.
Epidemiology
Pinta disease goes by another name, carate. It mostly happens in rural, poor areas of Central and South America, like Mexico, Central America and northern South America. More people get it in remote places with bad healthcare and sanitation facilities than in cities. Pinta’s spread isn’t fully known due to underreporting and issues tracking it. But there may be tens of thousands of cases yearly. Kids and young adults under age 15 tend to get pinta more often. This suggests that the disease spreads through close skin contact during childhood.
Anatomy
Pathophysiology
Pinta disease happens when Treponema carateum bacteria infect the body. It spreads mainly through direct skin contact, often in childhood. The bacteria enter through breaks in skin or mucous membranes. After entering, they travel via blood and lymph, colonizing tissues like skin. This triggers localized immune reactions. Inflammatory substances cause redness, swelling, and characteristic skin lesions. Over time, inflammation and bacterial damage create distinct lesions. These range from small, scaly patches to larger, discolored areas, often coppery or bluish. Untreated, pinta disease progresses, damaging skin and underlying tissues, potentially disfiguring or disabling. Sometimes, the immune system partially controls infection. This leads to chronic, low-grade infection persisting years or decades, with active periods and remissions.
Etiology
Pinta disease springs from a spiral-shaped germ called Treponema carateum. It’s closely akin to the bacterium causing syphilis, yet distinct in its effects and geographical footprint. This illness spreads mainly through skin-to-skin contact, often among kids in households or tight-knit communities. People are the prime hosts, with animals playing no major role in transmission. Pinta is endemic to certain Central and South American regions, thriving in rural, impoverished areas where healthcare and sanitation fall short, notably affecting countries like Mexico, Guatemala, Honduras, Nicaragua, Colombia, and Ecuador. Poverty, poor sanitation, overcrowding, and limited healthcare access heighten the risk of pinta’s spread and persistence. A lack of education and awareness about preventive steps compounds these issues.
Genetics
Prognostic Factors
Prognostic factors in pinta disease include many variables that can change how the disease turns out. With appropriate treatment, the prognosis is usually good. But some factors can impact the disease’s course. It’s really important to diagnose and start treatment early. Getting antibiotics like penicillin quickly plays a key role in controlling the disease and preventing complications. What stage the disease is in when diagnosed is significant too. Early-stage pinta typically responds well to treatment. Advanced-stage disease often doesn’t respond as well. The longer the infection goes untreated, the more damage it can cause to tissues. So it’s important to get treatment started early. How well a person’s immune system responds to Treponema carateum also impacts outcomes. Whether the person follows the treatment plan properly matters too. Socioeconomic factors also affect prognosis. Having good access to healthcare and education promotes timely diagnosis and better disease management. Regular follow-up care is essential for checking how well treatment is working. It also helps detect any relapse or complications early on. This contributes to long-term disease control.
Clinical History
Non-specific signs & symptoms
Systemic signs & symptoms
Age Group:
Physical Examination
Doctors look carefully at someone’s skin during an exam for pinta disease. They check any spots they find, looking at size, shape, and color. The spots are checked for textures like roughness or crusting. Doctors inspect each spot’s edges and check if there‘s scarring or wounds. Usually pinta doesn’t cause swollen lymph nodes, but doctors might feel for any swelling just in case. They might also check the patient’s overall health by looking at signs like temperature and appearance. However, pinta mainly affects the skin, so the skin exam is most important.
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Pinta disease has varying levels of severity. Its progression, immune response, and healthcare access influence it. After infection, small raised red spots or papules may develop at the bacterial entry point. These initial lesions often itch mildly. They may be mistaken for minor irritations. As the infection advances, characteristic skin lesions appear, differing in size, shape, and color, with texture changes like scaling, roughness, or crusting. A rash may spread while systemic symptoms remain minimal. Untreated, pinta disease transitions to a chronic phase with persistent skin lesions but diminishing symptoms and inflammation. This chronic phase follows a pattern of remission and relapse over years or decades, usually with milder manifestations than earlier stages.
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Pinta disease needs antibiotics to kill the bacteria causing it. Penicillin works best, especially when treated early. For people allergic, tetracycline or erythromycin also work fine. How long treatment lasts and the dosage depends on how bad the infection is. Some only need one round of antibiotics, but others may need longer treatment. Catching pinta early and treating properly is key. If left untreated, it can get worse with chronic, disfiguring skin lesions that spread.
Sanitation and hygiene improvements
Access to clean water and proper sanitation is key to fight pinta. Latrines, handwashing stations – these facilities reduce transmission risk. Health programs teaching good hygiene habits, like regular soap-and-water handwashing, are vital too. They help prevent disease spread. Simple measures like these make a big difference in combating pinta.
Housing and living conditions
Preventing pinta’s spread hinges on tackling overcrowded housing. Improving infrastructure or limiting household density curbs close contact spreading infection. Ensuring ventilation is key too. Good airflow creates a healthier environment, reducing pinta transmission risk.
Vector control
Spreading from person to person by skin touch, Pinta illness is mostly passed that way. But checking critters like fleas and lice assists too. Where lice bother folks a lot, maybe use bug nets treated with bug killer chemicals. All this aids limiting Pinta’s spread.
Community-based interventions
Community education helps inform about pinta disease. It teaches how it spreads and ways to avoid it. Knowledge empowers people to care for themselves properly. Identifying and tracing cases, along with treating patients and close contacts, can disrupt how pinta spreads through communities. Active case finding strategies are crucial in this effort.
Administration of antibiotics for the treatment of Pinta
Benzathine penicillin G: A single shot of benzathine penicillin G into the muscle treats early pinta. This regimen works best for those not allergic to penicillin. Highly effective, it eliminates the infection, stopping further spread.
Azithromycin: For bacterial infections, azithromycin is commonly prescribed. However, it’s not considered first-line treatment for pinta, a chronic condition caused by Treponema carateum. Pinta responds effectively to benzathine penicillin G, administered via intramuscular injection. This medication is the preferred choice for pinta’s treatment.
Treatment of advanced-stage or chronic pinta
Severe pinta cases need extensive antibiotic treatment. This could mean several injections or taking pills for a long time. Doctors choose the antibiotic and duration based on the patient’s condition and how they respond to the treatment.
Supportive care and management:
Treating pinta disease requires careful attention to wound care, ensuring cleanliness and dryness of affected areas. This vital step helps healing and prevents other infections. Additionally, prescribed treatments like corticosteroid creams or antihistamines provide relief from itching or discomfort caused by skin lesions. Proper care is crucial for effective pinta management.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Administration of antibiotics for the treatment of Pinta
Doxycycline: A tetracycline antibiotic known as doxycycline frequently treats bacterial infections. However, it’s not considered the primary choice for pinta, a long-lasting disease caused by Treponema carateum. The preferred initial treatment involves benzathine penicillin G, given through an injection into the muscle. This antibiotic has proven successful in curing pinta.
Erythromycin: Erythromycin, an antibiotic medicine, isn’t usually the go-to for treating pinta. Pinta’s a long-term illness from Treponema carateum germs. But sometimes, doctors might give erythromycin if penicillin’s off-limits or not around. A few studies hint it could work against those Treponema carateum bugs. Still, using erythromycin for pinta only happens when there’s no other choice.
Treatment of advanced-stage or chronic pinta
Supportive care and management:
Administration of other antibiotics, excluding penicillin, for the treatment of Pinta
Doxycycline is an antibiotic from the tetracycline class commonly used to treat various bacterial infections. However, it is not typically considered a first-line treatment for pinta, a chronic infectious disease caused by Treponema carateum.
The primary treatment for pinta is benzathine penicillin G, administered through intramuscular injection. This treatment has shown effectiveness in treating pinta and is the recommended first-line therapy.
Erythromycin, an antibiotic from the macrolide class, has been used to treat certain bacterial infections. However, it is not considered a first-line treatment for pinta, a chronic infectious disease caused by Treponema carateum.
In cases where penicillin is contraindicated or unavailable, alternative antibiotic options may be considered. Erythromycin has shown some effectiveness against Treponema carateum in limited studies and case reports, and it may be used as an alternative treatment for pinta in specific situations.
intervention-with-a-procedure
Pinta disease mostly impacts the skin and responds well to antibiotics, so it rarely needs procedures. Some circumstances do call for certain actions:
the-phase-of-management
In managing pinta disease, various stages occur, each with unique goals, actions. These involve:
Medication
Future Trends
Pinta disease, known as “carate” or “mal del Pinto,” causes discolored skin patches or lesions due to Treponema carateum bacteria. This chronic infection belongs to endemic treponematoses like syphilis and yaws. Transmission often happens during childhood through direct skin contact. Factors enabling pinta’s prevalence include poor hygiene conditions, overcrowded living spaces, and restricted healthcare access in affected areas.
Pinta disease goes by another name, carate. It mostly happens in rural, poor areas of Central and South America, like Mexico, Central America and northern South America. More people get it in remote places with bad healthcare and sanitation facilities than in cities. Pinta’s spread isn’t fully known due to underreporting and issues tracking it. But there may be tens of thousands of cases yearly. Kids and young adults under age 15 tend to get pinta more often. This suggests that the disease spreads through close skin contact during childhood.
Pinta disease happens when Treponema carateum bacteria infect the body. It spreads mainly through direct skin contact, often in childhood. The bacteria enter through breaks in skin or mucous membranes. After entering, they travel via blood and lymph, colonizing tissues like skin. This triggers localized immune reactions. Inflammatory substances cause redness, swelling, and characteristic skin lesions. Over time, inflammation and bacterial damage create distinct lesions. These range from small, scaly patches to larger, discolored areas, often coppery or bluish. Untreated, pinta disease progresses, damaging skin and underlying tissues, potentially disfiguring or disabling. Sometimes, the immune system partially controls infection. This leads to chronic, low-grade infection persisting years or decades, with active periods and remissions.
Pinta disease springs from a spiral-shaped germ called Treponema carateum. It’s closely akin to the bacterium causing syphilis, yet distinct in its effects and geographical footprint. This illness spreads mainly through skin-to-skin contact, often among kids in households or tight-knit communities. People are the prime hosts, with animals playing no major role in transmission. Pinta is endemic to certain Central and South American regions, thriving in rural, impoverished areas where healthcare and sanitation fall short, notably affecting countries like Mexico, Guatemala, Honduras, Nicaragua, Colombia, and Ecuador. Poverty, poor sanitation, overcrowding, and limited healthcare access heighten the risk of pinta’s spread and persistence. A lack of education and awareness about preventive steps compounds these issues.
Prognostic factors in pinta disease include many variables that can change how the disease turns out. With appropriate treatment, the prognosis is usually good. But some factors can impact the disease’s course. It’s really important to diagnose and start treatment early. Getting antibiotics like penicillin quickly plays a key role in controlling the disease and preventing complications. What stage the disease is in when diagnosed is significant too. Early-stage pinta typically responds well to treatment. Advanced-stage disease often doesn’t respond as well. The longer the infection goes untreated, the more damage it can cause to tissues. So it’s important to get treatment started early. How well a person’s immune system responds to Treponema carateum also impacts outcomes. Whether the person follows the treatment plan properly matters too. Socioeconomic factors also affect prognosis. Having good access to healthcare and education promotes timely diagnosis and better disease management. Regular follow-up care is essential for checking how well treatment is working. It also helps detect any relapse or complications early on. This contributes to long-term disease control.
Non-specific signs & symptoms
Systemic signs & symptoms
Age Group:
Doctors look carefully at someone’s skin during an exam for pinta disease. They check any spots they find, looking at size, shape, and color. The spots are checked for textures like roughness or crusting. Doctors inspect each spot’s edges and check if there‘s scarring or wounds. Usually pinta doesn’t cause swollen lymph nodes, but doctors might feel for any swelling just in case. They might also check the patient’s overall health by looking at signs like temperature and appearance. However, pinta mainly affects the skin, so the skin exam is most important.
Pinta disease has varying levels of severity. Its progression, immune response, and healthcare access influence it. After infection, small raised red spots or papules may develop at the bacterial entry point. These initial lesions often itch mildly. They may be mistaken for minor irritations. As the infection advances, characteristic skin lesions appear, differing in size, shape, and color, with texture changes like scaling, roughness, or crusting. A rash may spread while systemic symptoms remain minimal. Untreated, pinta disease transitions to a chronic phase with persistent skin lesions but diminishing symptoms and inflammation. This chronic phase follows a pattern of remission and relapse over years or decades, usually with milder manifestations than earlier stages.
Pinta disease needs antibiotics to kill the bacteria causing it. Penicillin works best, especially when treated early. For people allergic, tetracycline or erythromycin also work fine. How long treatment lasts and the dosage depends on how bad the infection is. Some only need one round of antibiotics, but others may need longer treatment. Catching pinta early and treating properly is key. If left untreated, it can get worse with chronic, disfiguring skin lesions that spread.
Sanitation and hygiene improvements
Access to clean water and proper sanitation is key to fight pinta. Latrines, handwashing stations – these facilities reduce transmission risk. Health programs teaching good hygiene habits, like regular soap-and-water handwashing, are vital too. They help prevent disease spread. Simple measures like these make a big difference in combating pinta.
Housing and living conditions
Preventing pinta’s spread hinges on tackling overcrowded housing. Improving infrastructure or limiting household density curbs close contact spreading infection. Ensuring ventilation is key too. Good airflow creates a healthier environment, reducing pinta transmission risk.
Vector control
Spreading from person to person by skin touch, Pinta illness is mostly passed that way. But checking critters like fleas and lice assists too. Where lice bother folks a lot, maybe use bug nets treated with bug killer chemicals. All this aids limiting Pinta’s spread.
Community-based interventions
Community education helps inform about pinta disease. It teaches how it spreads and ways to avoid it. Knowledge empowers people to care for themselves properly. Identifying and tracing cases, along with treating patients and close contacts, can disrupt how pinta spreads through communities. Active case finding strategies are crucial in this effort.
Administration of antibiotics for the treatment of Pinta
Benzathine penicillin G: A single shot of benzathine penicillin G into the muscle treats early pinta. This regimen works best for those not allergic to penicillin. Highly effective, it eliminates the infection, stopping further spread.
Azithromycin: For bacterial infections, azithromycin is commonly prescribed. However, it’s not considered first-line treatment for pinta, a chronic condition caused by Treponema carateum. Pinta responds effectively to benzathine penicillin G, administered via intramuscular injection. This medication is the preferred choice for pinta’s treatment.
Treatment of advanced-stage or chronic pinta
Severe pinta cases need extensive antibiotic treatment. This could mean several injections or taking pills for a long time. Doctors choose the antibiotic and duration based on the patient’s condition and how they respond to the treatment.
Supportive care and management:
Treating pinta disease requires careful attention to wound care, ensuring cleanliness and dryness of affected areas. This vital step helps healing and prevents other infections. Additionally, prescribed treatments like corticosteroid creams or antihistamines provide relief from itching or discomfort caused by skin lesions. Proper care is crucial for effective pinta management.
Doxycycline: A tetracycline antibiotic known as doxycycline frequently treats bacterial infections. However, it’s not considered the primary choice for pinta, a long-lasting disease caused by Treponema carateum. The preferred initial treatment involves benzathine penicillin G, given through an injection into the muscle. This antibiotic has proven successful in curing pinta.
Erythromycin: Erythromycin, an antibiotic medicine, isn’t usually the go-to for treating pinta. Pinta’s a long-term illness from Treponema carateum germs. But sometimes, doctors might give erythromycin if penicillin’s off-limits or not around. A few studies hint it could work against those Treponema carateum bugs. Still, using erythromycin for pinta only happens when there’s no other choice.
Supportive care and management:
Doxycycline is an antibiotic from the tetracycline class commonly used to treat various bacterial infections. However, it is not typically considered a first-line treatment for pinta, a chronic infectious disease caused by Treponema carateum.
The primary treatment for pinta is benzathine penicillin G, administered through intramuscular injection. This treatment has shown effectiveness in treating pinta and is the recommended first-line therapy.
Erythromycin, an antibiotic from the macrolide class, has been used to treat certain bacterial infections. However, it is not considered a first-line treatment for pinta, a chronic infectious disease caused by Treponema carateum.
In cases where penicillin is contraindicated or unavailable, alternative antibiotic options may be considered. Erythromycin has shown some effectiveness against Treponema carateum in limited studies and case reports, and it may be used as an alternative treatment for pinta in specific situations.
Pinta disease mostly impacts the skin and responds well to antibiotics, so it rarely needs procedures. Some circumstances do call for certain actions:
In managing pinta disease, various stages occur, each with unique goals, actions. These involve:
Pinta disease, known as “carate” or “mal del Pinto,” causes discolored skin patches or lesions due to Treponema carateum bacteria. This chronic infection belongs to endemic treponematoses like syphilis and yaws. Transmission often happens during childhood through direct skin contact. Factors enabling pinta’s prevalence include poor hygiene conditions, overcrowded living spaces, and restricted healthcare access in affected areas.
Pinta disease goes by another name, carate. It mostly happens in rural, poor areas of Central and South America, like Mexico, Central America and northern South America. More people get it in remote places with bad healthcare and sanitation facilities than in cities. Pinta’s spread isn’t fully known due to underreporting and issues tracking it. But there may be tens of thousands of cases yearly. Kids and young adults under age 15 tend to get pinta more often. This suggests that the disease spreads through close skin contact during childhood.
Pinta disease happens when Treponema carateum bacteria infect the body. It spreads mainly through direct skin contact, often in childhood. The bacteria enter through breaks in skin or mucous membranes. After entering, they travel via blood and lymph, colonizing tissues like skin. This triggers localized immune reactions. Inflammatory substances cause redness, swelling, and characteristic skin lesions. Over time, inflammation and bacterial damage create distinct lesions. These range from small, scaly patches to larger, discolored areas, often coppery or bluish. Untreated, pinta disease progresses, damaging skin and underlying tissues, potentially disfiguring or disabling. Sometimes, the immune system partially controls infection. This leads to chronic, low-grade infection persisting years or decades, with active periods and remissions.
Pinta disease springs from a spiral-shaped germ called Treponema carateum. It’s closely akin to the bacterium causing syphilis, yet distinct in its effects and geographical footprint. This illness spreads mainly through skin-to-skin contact, often among kids in households or tight-knit communities. People are the prime hosts, with animals playing no major role in transmission. Pinta is endemic to certain Central and South American regions, thriving in rural, impoverished areas where healthcare and sanitation fall short, notably affecting countries like Mexico, Guatemala, Honduras, Nicaragua, Colombia, and Ecuador. Poverty, poor sanitation, overcrowding, and limited healthcare access heighten the risk of pinta’s spread and persistence. A lack of education and awareness about preventive steps compounds these issues.
Prognostic factors in pinta disease include many variables that can change how the disease turns out. With appropriate treatment, the prognosis is usually good. But some factors can impact the disease’s course. It’s really important to diagnose and start treatment early. Getting antibiotics like penicillin quickly plays a key role in controlling the disease and preventing complications. What stage the disease is in when diagnosed is significant too. Early-stage pinta typically responds well to treatment. Advanced-stage disease often doesn’t respond as well. The longer the infection goes untreated, the more damage it can cause to tissues. So it’s important to get treatment started early. How well a person’s immune system responds to Treponema carateum also impacts outcomes. Whether the person follows the treatment plan properly matters too. Socioeconomic factors also affect prognosis. Having good access to healthcare and education promotes timely diagnosis and better disease management. Regular follow-up care is essential for checking how well treatment is working. It also helps detect any relapse or complications early on. This contributes to long-term disease control.
Non-specific signs & symptoms
Systemic signs & symptoms
Age Group:
Doctors look carefully at someone’s skin during an exam for pinta disease. They check any spots they find, looking at size, shape, and color. The spots are checked for textures like roughness or crusting. Doctors inspect each spot’s edges and check if there‘s scarring or wounds. Usually pinta doesn’t cause swollen lymph nodes, but doctors might feel for any swelling just in case. They might also check the patient’s overall health by looking at signs like temperature and appearance. However, pinta mainly affects the skin, so the skin exam is most important.
Pinta disease has varying levels of severity. Its progression, immune response, and healthcare access influence it. After infection, small raised red spots or papules may develop at the bacterial entry point. These initial lesions often itch mildly. They may be mistaken for minor irritations. As the infection advances, characteristic skin lesions appear, differing in size, shape, and color, with texture changes like scaling, roughness, or crusting. A rash may spread while systemic symptoms remain minimal. Untreated, pinta disease transitions to a chronic phase with persistent skin lesions but diminishing symptoms and inflammation. This chronic phase follows a pattern of remission and relapse over years or decades, usually with milder manifestations than earlier stages.
Pinta disease needs antibiotics to kill the bacteria causing it. Penicillin works best, especially when treated early. For people allergic, tetracycline or erythromycin also work fine. How long treatment lasts and the dosage depends on how bad the infection is. Some only need one round of antibiotics, but others may need longer treatment. Catching pinta early and treating properly is key. If left untreated, it can get worse with chronic, disfiguring skin lesions that spread.
Sanitation and hygiene improvements
Access to clean water and proper sanitation is key to fight pinta. Latrines, handwashing stations – these facilities reduce transmission risk. Health programs teaching good hygiene habits, like regular soap-and-water handwashing, are vital too. They help prevent disease spread. Simple measures like these make a big difference in combating pinta.
Housing and living conditions
Preventing pinta’s spread hinges on tackling overcrowded housing. Improving infrastructure or limiting household density curbs close contact spreading infection. Ensuring ventilation is key too. Good airflow creates a healthier environment, reducing pinta transmission risk.
Vector control
Spreading from person to person by skin touch, Pinta illness is mostly passed that way. But checking critters like fleas and lice assists too. Where lice bother folks a lot, maybe use bug nets treated with bug killer chemicals. All this aids limiting Pinta’s spread.
Community-based interventions
Community education helps inform about pinta disease. It teaches how it spreads and ways to avoid it. Knowledge empowers people to care for themselves properly. Identifying and tracing cases, along with treating patients and close contacts, can disrupt how pinta spreads through communities. Active case finding strategies are crucial in this effort.
Administration of antibiotics for the treatment of Pinta
Benzathine penicillin G: A single shot of benzathine penicillin G into the muscle treats early pinta. This regimen works best for those not allergic to penicillin. Highly effective, it eliminates the infection, stopping further spread.
Azithromycin: For bacterial infections, azithromycin is commonly prescribed. However, it’s not considered first-line treatment for pinta, a chronic condition caused by Treponema carateum. Pinta responds effectively to benzathine penicillin G, administered via intramuscular injection. This medication is the preferred choice for pinta’s treatment.
Treatment of advanced-stage or chronic pinta
Severe pinta cases need extensive antibiotic treatment. This could mean several injections or taking pills for a long time. Doctors choose the antibiotic and duration based on the patient’s condition and how they respond to the treatment.
Supportive care and management:
Treating pinta disease requires careful attention to wound care, ensuring cleanliness and dryness of affected areas. This vital step helps healing and prevents other infections. Additionally, prescribed treatments like corticosteroid creams or antihistamines provide relief from itching or discomfort caused by skin lesions. Proper care is crucial for effective pinta management.
Doxycycline: A tetracycline antibiotic known as doxycycline frequently treats bacterial infections. However, it’s not considered the primary choice for pinta, a long-lasting disease caused by Treponema carateum. The preferred initial treatment involves benzathine penicillin G, given through an injection into the muscle. This antibiotic has proven successful in curing pinta.
Erythromycin: Erythromycin, an antibiotic medicine, isn’t usually the go-to for treating pinta. Pinta’s a long-term illness from Treponema carateum germs. But sometimes, doctors might give erythromycin if penicillin’s off-limits or not around. A few studies hint it could work against those Treponema carateum bugs. Still, using erythromycin for pinta only happens when there’s no other choice.
Supportive care and management:
Doxycycline is an antibiotic from the tetracycline class commonly used to treat various bacterial infections. However, it is not typically considered a first-line treatment for pinta, a chronic infectious disease caused by Treponema carateum.
The primary treatment for pinta is benzathine penicillin G, administered through intramuscular injection. This treatment has shown effectiveness in treating pinta and is the recommended first-line therapy.
Erythromycin, an antibiotic from the macrolide class, has been used to treat certain bacterial infections. However, it is not considered a first-line treatment for pinta, a chronic infectious disease caused by Treponema carateum.
In cases where penicillin is contraindicated or unavailable, alternative antibiotic options may be considered. Erythromycin has shown some effectiveness against Treponema carateum in limited studies and case reports, and it may be used as an alternative treatment for pinta in specific situations.
Pinta disease mostly impacts the skin and responds well to antibiotics, so it rarely needs procedures. Some circumstances do call for certain actions:
In managing pinta disease, various stages occur, each with unique goals, actions. These involve:

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
